Australian Clinical Labs Ltd
ASX:ACL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.16
3.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Australian Clinical Labs Ltd
Net Margin
Australian Clinical Labs Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | AU |
| Market Cap | 700.8m AUD |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 91.8B USD |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 87.7B EUR |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 73B USD |
| Net Margin |
1%
|
| Country | DE |
| Market Cap | 24.9B EUR |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 20.1B USD |
| Net Margin |
3%
|
| Country | DE |
| Market Cap | 18.8B EUR |
| Net Margin |
-2%
|
| Country | US |
| Market Cap | 18.3B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 13.7B USD |
| Net Margin |
7%
|
| Country | DE |
| Market Cap | 12.4B EUR |
| Net Margin |
3%
|
| Country | AU |
| Market Cap | 13.4B AUD |
| Net Margin |
6%
|
Australian Clinical Labs Ltd
Glance View
Australian Clinical Labs Ltd. provides pathology services. The company is headquartered in Melbourne, Victoria and currently employs 2,794 full-time employees. The company went IPO on 2021-05-14. The firm is engaged in private hospital pathology businesses in regions of Western Australia, Victoria, South Australia and the Northern Territory. Its brands include Australian Clinical Labs, SunDoctors, Helix Pathology, Southern Sun, BeFunctional Labs and Gribbles Veterinary Pathology. The Australian Clinical Labs provides pathology in Australia, servicing clinicians, patients, hospitals, commercial clients and public organizations. The SunDoctors offers diagnosis and treatment of skin cancer. The Helix Pathology delivers specialized histopathology and cytology testing services. The Southern Sun is the skin cancer lab and the commercial lab in Australia. The BeFunctional Labs assists practitioners in the diagnosis, treatment and management of patients by providing functional pathology tests. The Gribbles Veterinary Pathology provides animal health professionals with pathology service.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Australian Clinical Labs Ltd's most recent financial statements, the company has Net Margin of 3.4%.
You don't have any saved screeners yet
